Healthy Living/WellnessFederal Jury Orders Gilead To Pay Merck $200 Million In Hepa C Drug Patent Dispute Merck is set to receive $200 million in damages from Gilead Sciences as federal jury decides on patent dispute. Merck claims they should be credited for liver therapy breakthrough.by Catherine Cabral-Isabedra
Healthy Living/WellnessThere Could Be Lead And Cadmium In Your Favorite Easter Candyby Lauren Keating
Healthy Living/WellnessForget Plasters, Forget Injections: Frog Foam May Be Future Antibiotic Carrierby Catherine Cabral-Isabedra
Healthy Living/WellnessFDA Issues Draft Guidance For Development Of Generic Anti-Abuse Opioidsby Rina Marie Doctor
Healthy Living/WellnessNot Just For Breast Cancer: Mammogram May Help Detect Heart Diseaseby Ted Ranosa
Healthy Living/WellnessMedical Experts Call On Governments To Decriminalize Minor Drug Offensesby Milafel Dacanay
Healthy Living/WellnessWoman Sues Yale Medical Center After Surgeons Removed Wrong Body Partby Katherine Derla
Healthy Living/WellnessGerber Recalls Batches Of Organic Fruit, Veggie Pouches Due To Possible Packaging Defectby Catherine Cabral-Isabedra
Healthy Living/WellnessCoffee And Pregnancy: Couple's High Caffeine Intake Linked To Higher Miscarriage Riskby Rhodi Lee
Healthy Living/WellnessThe Full English Breakfast Is Under Threat From Health Conscious Youngstersby Deepthi B